Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Prostatic Neoplasms 1

Interventions

Imiquimod 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Flow Cytometry 2Conization 2Colposcopy 2Biopsy 2poly ICLC 1motexafin lutetium 1human papillomavirus vaccine, TA 1Zoledronic Acid 1Vaccines, DNA 1Vaccines 1Transcription Activator-Like Effector Nucleases 1Sodium Chloride 1Polymerase Chain Reaction 1Photochemotherapy 1Microarray Analysis 1Interferon alpha-2 1Immunohistochemistry 1Hysterectomy 1Fluorescent Antibody Technique 1Fenofibrate 1Curcumin 1Chemoradiotherapy 1CRISPR-Associated Protein 9 1Blood Specimen Collection 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Uterine Cervical Dysplasia × motexafin lutetium × Clear all
NCT00005808 2013-02-07

Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia

National Cancer Institute (NCI)

Phase 1 Terminated
54 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡